HomeOPL • ASX
Opyl Ltd
$0.018
Oct 18, 7:00:00 PM GMT+11 · AUD · ASX · Disclaimer
StockAU listed security
Previous close
$0.018
Year range
$0.014 - $0.042
Market cap
3.07M AUD
Avg Volume
66.80K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD)Jun 2024Y/Y change
Revenue
76.98K-53.11%
Operating expense
421.40K55.20%
Net income
-927.04K-67.65%
Net profit margin
-1.20K-257.51%
Earnings per share
EBITDA
-909.06K-66.48%
Effective tax rate
Total assets
Total liabilities
(AUD)Jun 2024Y/Y change
Cash and short-term investments
374.64K-17.27%
Total assets
411.60K-41.99%
Total liabilities
501.76K-54.93%
Total equity
-90.16K
Shares outstanding
222.15M
Price to book
Return on assets
-556.44%
Return on capital
2,540.24%
Net change in cash
(AUD)Jun 2024Y/Y change
Net income
-927.04K-67.65%
Cash from operations
-738.29K-58.54%
Cash from investing
-8.86K-7,807.14%
Cash from financing
642.12K72.83%
Net change in cash
-105.03K-11.42%
Free cash flow
-171.58K42.93%
About
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics.. Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers. Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing. ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Founded
2013
Website
Employees
3
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu